how does tirzepatide compare to semaglutide for weight loss vs. Semaglutide: Which Medication is Right You? Comparing Semaglutide and Tirzepatide for

New England Journal of Medicine (2025) The REDEFINE 2 Phase 3 trial evaluated CagriSema in 1,206 adults with overweight or obesity and type 2 diabetes in a 68-week, double-blind, placebo-controlled design

Table 1 presents the baseline demographic and clinical characteristics of all participants, while Table 2 presents the differences in assessed parameters and their significance between the baseline and the one-year follow-up in 82 completers

That gap between what a lab report says and what you actually experience is not in your head, and understanding why it exists might be one of the most important things

At TrimRx, safety is a cornerstone of our personalized weight loss solutions

Call 806-503-2556 or visit our Lubbock location to schedule your consultation today

Retatrutide Phase 2 Trial Results The Phase 2 trial published in the New England Journal of Medicine (2023) showed impressive results at 48 weeks: Tirzepatide SURMOUNT-1 Trial Results The SURMOUNT-1 trial for obesity treatment showed results at 72 weeks: Important Trial Comparison Note Retatrutide's 24.2% came at 48 weeks